Svjetlana Lovric

4.8k total citations
26 papers, 734 citations indexed

About

Svjetlana Lovric is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Svjetlana Lovric has authored 26 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 8 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Svjetlana Lovric's work include Renal Diseases and Glomerulopathies (12 papers), Complement system in diseases (5 papers) and Vasculitis and related conditions (5 papers). Svjetlana Lovric is often cited by papers focused on Renal Diseases and Glomerulopathies (12 papers), Complement system in diseases (5 papers) and Vasculitis and related conditions (5 papers). Svjetlana Lovric collaborates with scholars based in Germany, United States and United Kingdom. Svjetlana Lovric's co-authors include Shazia Ashraf, Friedhelm Hildebrandt, Weizhen Tan, Marion Haubitz, Heon Yung Gee, Carolin E. Sadowski, Virginia Vega-Warner, Humphrey Fang, Jan T. Kielstein and Hermann Haller and has published in prestigious journals such as PLoS ONE, Journal of the American Society of Nephrology and The American Journal of Human Genetics.

In The Last Decade

Svjetlana Lovric

24 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Svjetlana Lovric Germany 13 387 297 135 118 117 26 734
Yuko Shima Japan 19 598 1.5× 428 1.4× 211 1.6× 72 0.6× 312 2.7× 61 1.2k
Roberta Bertelli Italy 18 728 1.9× 356 1.2× 121 0.9× 199 1.7× 237 2.0× 37 1.1k
Junjun Zhang China 17 236 0.6× 181 0.6× 236 1.7× 66 0.6× 63 0.5× 46 879
Chang Ying Xing China 4 733 1.9× 453 1.5× 61 0.5× 71 0.6× 83 0.7× 5 987
Timothy Farren United Kingdom 9 695 1.8× 440 1.5× 58 0.4× 173 1.5× 146 1.2× 15 1.1k
Tomohiro Udagawa Japan 9 184 0.5× 198 0.7× 37 0.3× 66 0.6× 84 0.7× 25 516
Fanny Oliveira Arcolino Belgium 15 117 0.3× 329 1.1× 101 0.7× 83 0.7× 173 1.5× 28 725
Bettina E. Mucha United States 14 1.0k 2.6× 665 2.2× 153 1.1× 225 1.9× 256 2.2× 18 1.3k
Akiko Oguchi Japan 9 211 0.5× 300 1.0× 94 0.7× 66 0.6× 30 0.3× 19 631
Cristina López-Blau Spain 4 225 0.6× 451 1.5× 122 0.9× 34 0.3× 52 0.4× 5 766

Countries citing papers authored by Svjetlana Lovric

Since Specialization
Citations

This map shows the geographic impact of Svjetlana Lovric's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Svjetlana Lovric with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Svjetlana Lovric more than expected).

Fields of papers citing papers by Svjetlana Lovric

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Svjetlana Lovric. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Svjetlana Lovric. The network helps show where Svjetlana Lovric may publish in the future.

Co-authorship network of co-authors of Svjetlana Lovric

This figure shows the co-authorship network connecting the top 25 collaborators of Svjetlana Lovric. A scholar is included among the top collaborators of Svjetlana Lovric based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Svjetlana Lovric. Svjetlana Lovric is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Konen, Franz Felix, Nora Möhn, Torsten Witte, et al.. (2025). Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders. Autoimmunity Reviews. 24(4). 103754–103754.
2.
Kaufeld, Jessica & Svjetlana Lovric. (2024). Was ist gesichert in der Therapie komplementvermittelter Nierenerkrankungen?. Die Innere Medizin. 65(12). 1216–1224.
3.
Hinze, Christian, Svjetlana Lovric, Philip F. Halloran, Jonathan Barasch, & Kai M. Schmidt‐Ott. (2024). Epithelial cell states associated with kidney and allograft injury. Nature Reviews Nephrology. 20(7). 447–459. 5 indexed citations
4.
Konen, Franz Felix, Nora Möhn, Torsten Witte, et al.. (2023). Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders. Autoimmunity Reviews. 22(5). 103312–103312. 32 indexed citations
5.
Liu, Pei‐Ju, Chunling Zhang, Jing Bi‐Karchin, et al.. (2022). Steroid-Resistant Nephrotic Syndrome–Associated MYO1E Mutations Have Differential Effects on Myosin 1e Localization, Dynamics, and Activity. Journal of the American Society of Nephrology. 33(11). 1989–2007. 4 indexed citations
6.
Fleig, Susanne, Franz Felix Konen, Christoph Schröder, et al.. (2021). Long‐term B cell depletion associates with regeneration of kidney function. Immunity Inflammation and Disease. 9(4). 1479–1488. 6 indexed citations
7.
Wang, Fang, Yanqin Zhang, Jianhua Mao, et al.. (2017). Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome. Pediatric Nephrology. 32(7). 1181–1192. 75 indexed citations
8.
Tan, Weizhen, Svjetlana Lovric, Shazia Ashraf, et al.. (2017). Analysis of 24 genes reveals a monogenic cause in 11.1% of cases with steroid-resistant nephrotic syndrome at a single center. Pediatric Nephrology. 33(2). 305–314. 24 indexed citations
9.
Lovric, Svjetlana, Shazia Ashraf, Weizhen Tan, & Friedhelm Hildebrandt. (2015). Genetic testing in steroid-resistant nephrotic syndrome: when and how?. Nephrology Dialysis Transplantation. 31(11). 1802–1813. 133 indexed citations
10.
Lovric, Svjetlana, Humphrey Fang, Virginia Vega-Warner, et al.. (2014). Rapid Detection of Monogenic Causes of Childhood-Onset Steroid-Resistant Nephrotic Syndrome. Clinical Journal of the American Society of Nephrology. 9(6). 1109–1116. 55 indexed citations
11.
Ebarasi, Lwaki, Shazia Ashraf, Agnieszka Bierżyńska, et al.. (2014). Defects of CRB2 Cause Steroid-Resistant Nephrotic Syndrome. The American Journal of Human Genetics. 96(1). 153–161. 81 indexed citations
12.
Englbrecht, Matthias, Svjetlana Lovric, A. Sämann, et al.. (2013). Coping strategies and depressiveness in primary systemic vasculitis—what is their impact on health-related quality of life?. Lara D. Veeken. 52(10). 1856–1864. 15 indexed citations
13.
Vester, Udo, Thurid Ahlenstiel, Ulrich Budde, et al.. (2013). Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS). Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 462(4). 455–464. 8 indexed citations
14.
Tutarel, Oktay, Stefanie M. Bode‐Böger, Jens Martens‐Lobenhoffer, et al.. (2012). Asymmetrical Dimethylarginine - More Sensitive than NT-proBNP to Diagnose Heart Failure in Adults with Congenital Heart Disease. PLoS ONE. 7(3). e33795–e33795. 25 indexed citations
15.
Bockmeyer, Clemens L., Drew S. Kern, Svjetlana Lovric, et al.. (2012). Arteriolar vascular smooth muscle cell differentiation in benign nephrosclerosis. Nephrology Dialysis Transplantation. 27(9). 3493–3501. 11 indexed citations
16.
Deb‐Chatterji, Milani, Hans Worthmann, Annemarie Goldbecker, et al.. (2012). Circulating endothelial cells as potential diagnostic biomarkers in primary central nervous system vasculitis. Journal of Neurology Neurosurgery & Psychiatry. 84(7). 732–734. 8 indexed citations
17.
Lorenzen, Johan M., Svjetlana Lovric, Robert S. Kramer, Hermann Haller, & Marion Haubitz. (2010). Osteopontin in antineutrophil cytoplasmic autoantibody-associated vasculitis: relation to disease activity, organ manifestation and immunosuppressive therapy. Annals of the Rheumatic Diseases. 69(6). 1169–1171. 8 indexed citations
18.
Bockmeyer, Clemens L., Svjetlana Lovric, Ralf A. Claus, et al.. (2010). ADAMTS13--marker of contractile phenotype of arterial smooth muscle cells lost in benign nephrosclerosis. Nephrology Dialysis Transplantation. 26(6). 1871–1881. 6 indexed citations
19.
Hafer, Carsten, Jan T. Kielstein, Marion Haubitz, et al.. (2010). Removal of elevated circulating angiopoietin-2 by plasma exchange – A pilot study in critically ill patients with thrombotic microangiopathy and anti-glomerular basement membrane disease. Thrombosis and Haemostasis. 104(11). 1038–1043. 12 indexed citations
20.
Lovric, Svjetlana, Uta Erdbrüegger, P. Kumpers, et al.. (2008). Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients. Nephrology Dialysis Transplantation. 24(1). 179–185. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026